Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trials
3 recruiting trials for Metabolic Dysfunction-Associated Steatotic Liver Disease. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT06138821
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modification is the...
Sponsor: Pichamol Jirapinyo, MD, MPHEnrolling: 1322 locations
RECRUITINGNCT06495333
Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the most common cause of liver disease worldwide. The condition is defined by fat accumulation exceeding 5% of...
Sponsor: Fundacion de Investigacion Science and EducationEnrolling: 1001 location
RECRUITINGNCT06873165
Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to...
The goal of this clinical trial is to investigate the efficacy and safety of pasteurized Akkermansia muciniphila strain NTUH\_Amuc03 (pAKK NTUH\_Amuc03) in Metabolic...
Sponsor: National Taiwan University HospitalEnrolling: 401 location